AGUIRRE PÉREZ, A. et al. 2025. antidyskinetic effect of the H₃ agonist immepip is accompanied by a reduction in thalamic GABA levels in hemiparkinsonian rats chronically treated with L-DOPA. Investigación en Discapacidad. 11, S1 (Nov. 2025).